Pacira Pharmaceuticals, Inc. 4
4 · Pacira Pharmaceuticals, Inc. · Filed Sep 27, 2013
Insider Transaction Report
Form 4
Markvicka Taunia
Vice President, Commercial
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2013-09-25−10,000→ 8,349 totalExercise: $5.49Exp: 2020-12-28→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2013-09-25$5.49/sh+10,000$54,900→ 10,000 total - Sale
Common Stock
2013-09-25$47.00/sh−10,000$470,000→ 0 total
Footnotes (2)
- [F1]The exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]The stock option vests as follows: 25% of the options vested on December 29, 2011; the remaining options vest in successive equal monthly installments over the subsequent 36 months.